September 02, 2026

Is remote robotic subretinal injection feasible?

A remote surgeon completed the precision injection without intraoperative complications in a single-case proof-of-concept report.

MDSpire News

September 02, 2026

The Retina’s Hidden Polarization Patterns

How structured light could reveal a new window into retinal function

The Ophthalmologist

September 01, 2026

Glycemic variability may signal retinal changes

Greater glucose fluctuations but not HbA1c were associated with neuroretinal alterations over 3 years in pediatric patients with type 1 diabetes.

MDSpire News

August 10, 2026

EyePoint Completes Enrollment in Phase 3 DME Trials

More than 480 patients have joined the COMO and CAPRI studies evaluating six-month dosing of EyePoint’s investigational retinal therapy, DURAVYU

The Ophthalmologist

August 06, 2026

Sharper Targets for Retinal Repair

Researchers map distinct photoreceptor precursor states that could help refine future cell therapies for retinal degeneration

The Ophthalmologist

August 03, 2026

Enzyme Disruption Could Impair Retinal Homeostasis

Preclinical models showed that impaired endolysosomal trafficking preceded photoreceptor degeneration and disrupted retinal pigment epithelial cell function.

MDSpire News

July 24, 2026

FDA Approves Ophthalmic Bevacizumab

The approval establishes the first and only FDA-approved ophthalmic formulation of bevacizumab for neovascular age-related macular degeneration in the US.

MDSpire News

July 22, 2026

Looking Deeper With STOC-T

New review explores how spatio-temporal optical coherence tomography preserves useful photons and suppresses scattered light

The Ophthalmologist

July 20, 2026

Can Oral Gildeuretinol Slow Advanced Macular Degeneration?

Although the trial missed its primary endpoint, exploratory analyses suggested slower lesion growth and better functional outcomes with gildeuretinol.

MDSpire News

July 15, 2026

Stuart Therapeutics Spotlights Topical RP Program

At OIS Retina, Eric Schlumpf discussed the company’s collagen mimetic peptide platform for retinitis pigmentosa, now in preclinical development.

Retinal Physician